They recruited 111 patients with histologically confirmed large B cell lymphoma, including DLBCL and primary mediastinal B cell lymphoma, and autologous anti-CD19 CAR-T cells were inoculated at 2 × 106 cells/kg body weight. The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.